Concepedia
Statistics
Publications
55
Citations
4.3K
H-Index
29
Active since
1998
Affiliations
GlaxoSmithKline (United States)(Current)
The University of Texas MD Anderson Cancer Center
Research Triangle Park Foundation
Genmab (Denmark)
Dana-Farber Cancer Institute
Ira Gupta is an author at GlaxoSmithKline (United States) specializing in medicine, immunotherapy, and cancer immunotherapy.
Publications per year
1998–2023
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · The Lancet Oncology · 2019 · 796 citations
Medicine, Pharmacology, Pharmacotherapy +11
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
Peter Hillmen, Tadeusz Robak, Ann Janssens et al. · The Lancet · 2015 · 339 citations
Life Sciences, Oncology, Pharmacology +17
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi et al. · Blood · 2018 · 329 citations · Full text
Medicine, Hematology, Oncology +13
Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study.
Ira Gupta, Gupta, Anurag Parihar et al. · PubMed · 1998 · 269 citations
Pharmacy, Internal Medicine, Pharmacotherapy +5
Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat et al. · Blood Cancer Journal · 2019 · 213 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
1–5 of 55